Scholars Central

Conference abstractPublished 30 Jan 2017

Non-transpeptidase binding aryl-thioether Ã?²-lactams active against Mycobacterium tuberculosis

Authors: Monika I Konaklieva, Rostislav Kuskovsky, Kriti Arora

American University, USA National Institute of Allergy and Infectious Diseases, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We have designed, synthesized and tested a novel class of non-transpeptidase, Ã?²-lactamase resistant monocyclic Ã?²-lactams that carry an aryl-thio group at C4. These thio-ethers exhibit inhibitory and cidal activity against serine Ã?²-lactamase producing Mycobacterium tuberculosis wild type strain (Mtb). Some of the compounds have demonstrated minimal inhibitory concentration (MIC) as low as 6.25 Ã?¼g/ml in 7H9 and 1.5 Ã?¼g/ml in GAST. Our investigations indicate that these compounds are cidal to both replicating and non-replicating persistent Mtb. These compounds have also shown activity against multi-drug resistant strains of M. tuberculosis. Therefore, they are promising candidates for lead discovery. Mechanism of action and target identification studies which are currently underway.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Monika I Konaklieva”
  • BylineArticles whose byline prints “Rostislav Kuskovsky”
  • BylineArticles whose byline prints “Kriti Arora”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels